Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis

Nizar Chahin, Eric J. Sorenson

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

We compared serum creatine kinase (CK) levels between spinobulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS) and reviewed available histochemical studies of frozen sections of muscle biopsies. CK levels and the frequency of patients with elevated CK levels were significantly higher in the SBMA group when compared with the ALS group. CK levels occasionally approached values up to 8 times the upper limit of normal in the SBMA group. In addition to the chronic neurogenic changes in the muscle biopsy, all SBMA patients showed one or more myopathic changes. Increased numbers of markedly hypertrophic fibers were consistently seen in all patients. It is not clear whether the elevated CK level is directly related to the increased number of hypertrophic fibers or to other myopathic features. Based on these findings, we recommend genetic testing for SBMA in cases of male patients with motor neuron disease who present with a significantly elevated serum creatine kinase level, even when other characteristic clinical features of SBMA are absent.

Original languageEnglish (US)
Pages (from-to)126-129
Number of pages4
JournalMuscle and Nerve
Volume40
Issue number1
DOIs
StatePublished - Jul 2009

Fingerprint

Atrophic Muscular Disorders
Amyotrophic Lateral Sclerosis
Creatine Kinase
Serum
Biopsy
Muscles
Motor Neuron Disease
Frozen Sections
Genetic Testing

Keywords

  • Amyotrophic lateral sclerosis
  • Creatine kinase
  • Hypertrophic fibers
  • Prognosis
  • Spinobulbar muscular atrophy

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)
  • Physiology

Cite this

Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. / Chahin, Nizar; Sorenson, Eric J.

In: Muscle and Nerve, Vol. 40, No. 1, 07.2009, p. 126-129.

Research output: Contribution to journalArticle

@article{3e857138195b43c98287bc48851972d0,
title = "Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis",
abstract = "We compared serum creatine kinase (CK) levels between spinobulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS) and reviewed available histochemical studies of frozen sections of muscle biopsies. CK levels and the frequency of patients with elevated CK levels were significantly higher in the SBMA group when compared with the ALS group. CK levels occasionally approached values up to 8 times the upper limit of normal in the SBMA group. In addition to the chronic neurogenic changes in the muscle biopsy, all SBMA patients showed one or more myopathic changes. Increased numbers of markedly hypertrophic fibers were consistently seen in all patients. It is not clear whether the elevated CK level is directly related to the increased number of hypertrophic fibers or to other myopathic features. Based on these findings, we recommend genetic testing for SBMA in cases of male patients with motor neuron disease who present with a significantly elevated serum creatine kinase level, even when other characteristic clinical features of SBMA are absent.",
keywords = "Amyotrophic lateral sclerosis, Creatine kinase, Hypertrophic fibers, Prognosis, Spinobulbar muscular atrophy",
author = "Nizar Chahin and Sorenson, {Eric J.}",
year = "2009",
month = "7",
doi = "10.1002/mus.21310",
language = "English (US)",
volume = "40",
pages = "126--129",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis

AU - Chahin, Nizar

AU - Sorenson, Eric J.

PY - 2009/7

Y1 - 2009/7

N2 - We compared serum creatine kinase (CK) levels between spinobulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS) and reviewed available histochemical studies of frozen sections of muscle biopsies. CK levels and the frequency of patients with elevated CK levels were significantly higher in the SBMA group when compared with the ALS group. CK levels occasionally approached values up to 8 times the upper limit of normal in the SBMA group. In addition to the chronic neurogenic changes in the muscle biopsy, all SBMA patients showed one or more myopathic changes. Increased numbers of markedly hypertrophic fibers were consistently seen in all patients. It is not clear whether the elevated CK level is directly related to the increased number of hypertrophic fibers or to other myopathic features. Based on these findings, we recommend genetic testing for SBMA in cases of male patients with motor neuron disease who present with a significantly elevated serum creatine kinase level, even when other characteristic clinical features of SBMA are absent.

AB - We compared serum creatine kinase (CK) levels between spinobulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS) and reviewed available histochemical studies of frozen sections of muscle biopsies. CK levels and the frequency of patients with elevated CK levels were significantly higher in the SBMA group when compared with the ALS group. CK levels occasionally approached values up to 8 times the upper limit of normal in the SBMA group. In addition to the chronic neurogenic changes in the muscle biopsy, all SBMA patients showed one or more myopathic changes. Increased numbers of markedly hypertrophic fibers were consistently seen in all patients. It is not clear whether the elevated CK level is directly related to the increased number of hypertrophic fibers or to other myopathic features. Based on these findings, we recommend genetic testing for SBMA in cases of male patients with motor neuron disease who present with a significantly elevated serum creatine kinase level, even when other characteristic clinical features of SBMA are absent.

KW - Amyotrophic lateral sclerosis

KW - Creatine kinase

KW - Hypertrophic fibers

KW - Prognosis

KW - Spinobulbar muscular atrophy

UR - http://www.scopus.com/inward/record.url?scp=67650240395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650240395&partnerID=8YFLogxK

U2 - 10.1002/mus.21310

DO - 10.1002/mus.21310

M3 - Article

C2 - 19533663

AN - SCOPUS:67650240395

VL - 40

SP - 126

EP - 129

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 1

ER -